5 Einträge gefunden

1. Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignancies

   1. Schriewer, Levin
   2. Schütze, Kerstin
   3. Petry, Katharina
   4. Hambach, Julia
   5. Fumey, William
   6. Koenigsdorf, Julia
   7. Baum, Natalie

   2020 - Forschungsinformationssystem des UKE
2. Nanobody-targeting of epidermal growth factor receptor (EGFR) ectodomain variants overcomes resistance to therapeutic EGFR antibodies

   1. Tintelnot, Joseph
   2. Baum, Natalie
   3. Schultheiss, Christoph
   4. Braig, Friederike
   5. Trentmann, Marie
   6. Finter, Johannes
   7. Fumey, William

   2019 - Forschungsinformationssystem des UKE
3. CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells

   1. Schütze, Kerstin
   2. Petry, Katharina
   3. Hambach, Julia
   4. Schuster, Niklas
   5. Fumey, William
   6. Schriewer, Levin
   7. Rockendorf, Jana

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
4. Nanobodies effectively modulate the enzymatic activity of CD38 and allow specific imaging of CD38+ tumors in mouse models in vivo

   1. Fumey, William
   2. Koenigsdorf, Julia
   3. Kunick, Valentin
   4. Menzel, Stephan
   5. Schütze, Kerstin
   6. Unger, Mandy
   7. Schriewer, Levin

   2017 - Forschungsinformationssystem des UKE - frei zugänglich
5. Molecular imaging of tumors with nanobodies and antibodies: Timing and dosage are crucial factors for improved in vivo detection

   1. Bannas, Peter
   2. Lenz, Alexander
   3. Kunick, Valentin
   4. Well, Lennart
   5. Fumey, William
   6. Rissiek, Björn
   7. Haag, Friedrich

   2015 - Forschungsinformationssystem des UKE - frei zugänglich